advertisement
García-Feijoó J 20
Showing records 1 to 20 | Display all abstracts from García-Feijoó J91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Konstas AG
Expert Opinion on Drug Safety 2021; 0: 1-14
91099 CPAMD8 loss-of-function underlies non-dominant congenital glaucoma with variable anterior segment dysgenesis and abnormal extracellular matrix
Bonet-Fernández JM
Human Genetics 2020; 139: 1209-1231
91229 Aniridic glaucoma: An update
Muñoz-Negrete FJ
Archivos de la Sociedad Española de Oftalmologia 2021; 0:
91099 CPAMD8 loss-of-function underlies non-dominant congenital glaucoma with variable anterior segment dysgenesis and abnormal extracellular matrix
Aroca-Aguilar JD
Human Genetics 2020; 139: 1209-1231
91229 Aniridic glaucoma: An update
Teus MÁ
Archivos de la Sociedad Española de Oftalmologia 2021; 0:
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Labbé A; Katsanos A
Expert Opinion on Drug Safety 2021; 0: 1-14
91099 CPAMD8 loss-of-function underlies non-dominant congenital glaucoma with variable anterior segment dysgenesis and abnormal extracellular matrix
Corton M
Human Genetics 2020; 139: 1209-1231
91229 Aniridic glaucoma: An update
García-Feijoó J; Canut MI
Archivos de la Sociedad Española de Oftalmologia 2021; 0:
91099 CPAMD8 loss-of-function underlies non-dominant congenital glaucoma with variable anterior segment dysgenesis and abnormal extracellular matrix
Ramírez AI
Human Genetics 2020; 139: 1209-1231
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Meier-Gibbons F
Expert Opinion on Drug Safety 2021; 0: 1-14
91099 CPAMD8 loss-of-function underlies non-dominant congenital glaucoma with variable anterior segment dysgenesis and abnormal extracellular matrix
Alexandre-Moreno S
Human Genetics 2020; 139: 1209-1231
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
İrkeç M
Expert Opinion on Drug Safety 2021; 0: 1-14
91229 Aniridic glaucoma: An update
Rebolleda G
Archivos de la Sociedad Española de Oftalmologia 2021; 0:
91099 CPAMD8 loss-of-function underlies non-dominant congenital glaucoma with variable anterior segment dysgenesis and abnormal extracellular matrix
García-Antón MT
Human Genetics 2020; 139: 1209-1231
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Boboridis KG; Holló G
Expert Opinion on Drug Safety 2021; 0: 1-14
91099 CPAMD8 loss-of-function underlies non-dominant congenital glaucoma with variable anterior segment dysgenesis and abnormal extracellular matrix
Salazar JJ; Ferre-Fernández JJ
Human Genetics 2020; 139: 1209-1231
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
García-Feijoó J; Dutton GN
Expert Opinion on Drug Safety 2021; 0: 1-14
91099 CPAMD8 loss-of-function underlies non-dominant congenital glaucoma with variable anterior segment dysgenesis and abnormal extracellular matrix
Atienzar-Aroca R
Human Genetics 2020; 139: 1209-1231
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Baudouin C
Expert Opinion on Drug Safety 2021; 0: 1-14
91099 CPAMD8 loss-of-function underlies non-dominant congenital glaucoma with variable anterior segment dysgenesis and abnormal extracellular matrix
Villaverde C; Iancu I; Tamayo A; Méndez-Hernández CD; Morales-Fernández L; Rojas B; Ayuso C; Coca-Prados M; Martínez-de-la-Casa JM; García-Feijoó J; Escribano J
Human Genetics 2020; 139: 1209-1231
